Citadel Advisors
MLSS icon

Citadel Advisors’s Milestone Scientific MLSS Stock Holding History

Citadel Advisors’s Portfolio MLSS Stock Details MLSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-167,135
Closed -$48.1K – 14424
2026
Q1 		$48.1K Buy
167,135
+13,360
+9% +$3.73K ﹤0.01% 12417
2025
Q4 		$42K Buy
+153,775
New +$58.5K ﹤0.01% 12117
2025
Q3 		– Sell
-39,642
Closed -$25.2K – 13598
2025
Q2 		$25.2K Buy
+39,642
New +$36.4K ﹤0.01% 12053
2025
Q1 		– Sell
-62,438
Closed -$68.5K – 15171
2024
Q4 		$59.9K Buy
62,438
+39,274
+170% +$32.4K ﹤0.01% 12181
2024
Q3 		$21.1K Sell
23,164
-31,169
-57% -$29.2K ﹤0.01% 12737
2024
Q2 		$37.1K Buy
54,333
+14,286
+36% +$9.5K ﹤0.01% 12062
2024
Q1 		$24.9K Sell
40,047
-8,541
-18% -$5.61K ﹤0.01% 12850
2023
Q4 		$33.5K Buy
48,588
+8,694
+22% +$6.93K ﹤0.01% 12178
2023
Q3 		$36.7K Sell
39,894
-49,848
-56% -$52.5K ﹤0.01% 12100
2023
Q2 		$78.1K Buy
+89,742
New +$80.8K ﹤0.01% 11271
2023
Q1 		– Sell
-73,092
Closed -$35.1K – 15184
2022
Q4 		$35.1K Buy
73,092
+15,781
+28% +$10.2K ﹤0.01% 12563
2022
Q3 		$45K Sell
57,311
-99,111
-63% -$96.1K ﹤0.01% 11704
2022
Q2 		$143K Buy
156,422
+143,473
+1,108% +$146K ﹤0.01% 11030
2022
Q1 		$20K Sell
12,949
-29,303
-69% -$42.8K ﹤0.01% 13241
2021
Q4 		$87K Buy
+42,252
New +$92.9K ﹤0.01% 12846
2021
Q3 		– Sell
-25,326
Closed -$62K – 14335
2021
Q2 		$62K Buy
+25,326
New +$61.4K ﹤0.01% 13230
2021
Q1 		– Sell
-29,535
Closed -$63K – 13526
2020
Q4 		$63K Buy
+29,535
New +$52K ﹤0.01% 10476
2019
Q2 		– Sell
-80,914
Closed -$27K – 9599
2019
Q1 		$27K Buy
80,914
+53,592
+196% +$19.7K ﹤0.01% 9013
2018
Q4 		$9K Buy
27,322
+10,736
+65% +$5.75K ﹤0.01% 8938
2018
Q3 		$12K Buy
+16,586
New +$13.2K ﹤0.01% 9092
2017
Q2 		– Sell
-12,787
Closed -$17K – 7840
2017
Q1 		$17K Buy
+12,787
New +$17.9K ﹤0.01% 7288

Other funds holding MLSS

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $808M AUM 51.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $4.99B AUM 23.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Citadel Advisors's MLSS Position: Q2 2026 in Review

Citadel Advisors sold out of Milestone Scientific (MLSS) in Q2 2026, closing a stake of 167,135 shares — an estimated $48.1K sold.

Citadel Advisors first reported a position in MLSS in Q1 2017 and held it in 21 quarters. The position peaked at $143K in Q2 2022. 29 funds tracked by Wall St. Rank hold MLSS as of Q2 2026.

  • Citadel Advisors reported no remaining Milestone Scientific position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 167,135 Milestone Scientific shares in Q2 2026, an estimated $48.1K.
  • Citadel Advisors first reported a position in Milestone Scientific in Q1 2017 and held it in 21 quarters.
  • Citadel Advisors's Milestone Scientific position peaked at $143K in Q2 2022.
  • 29 funds tracked by Wall St. Rank held Milestone Scientific as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.